MDGL compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

MDGLMadrigal Pharmaceuticals, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

MDGLMadrigal Pharmaceuticals, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

MDGL

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±10.5%▼−9.83%×0.93

Q1 FY26±9.2%▲+7.42%×0.80

Feb 19 '26±6.2%▼−11.11%×1.79

Nov 4 '25±12.9%▲+7.83%×0.60

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

= impliedMDGL realized, solidLLY realized, hatchedOne scale, both sides: full bar = 13%× = |realized| ÷ impliedSource: market data

Q1 FY26

±5.3%

▲+9.80%

×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

MDGLMadrigal Pharmaceuticals, Inc.

432.96▲+0.60%· post 432.96· delayed

Mkt cap$9.9BRevenue$364MQ2 FY26Revenue$958MFY25

LLYELI Lilly & Co

1,418.01▲+0.03%· post 1,411.43· delayed

After hoursNov 2 '26delayed

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

After hoursNov 2 '26delayed

MDGLMadrigal Pharmaceuticals, Inc.

LLYELI Lilly & Co

432.96▲+0.60%post 432.96delayed

Price

1,418.01▲+0.03%post 1,411.43delayed

$9.9B

Mkt cap

$1.3T

Q2 FY26$364M

Revenue

$24.4BQ3 FY26

FY25$958M

Revenue

$65.2BFY25

MDGL432.96▲+0.60%vsLLY1,418.01▲+0.03%After hoursNov 2 '26delayed